Loading…
A one-tube rapid visual CRISPR assay for the field detection of Japanese encephalitis virus
•RApid VIsual (RAVI)-CRISPR assay for on-site detection of Japanese encephalitis virus (JEV) was established.•The limit of detection of RAVI-CRISPR assay was up to 9 copies/μl JEV RNA and no cross-reactivity with other viruses.•Naked-eye one-tube RAVI-CRISPR assay for point-of-care testing of JEV wa...
Saved in:
Published in: | Virus research 2022-10, Vol.319, p.198869-198869, Article 198869 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •RApid VIsual (RAVI)-CRISPR assay for on-site detection of Japanese encephalitis virus (JEV) was established.•The limit of detection of RAVI-CRISPR assay was up to 9 copies/μl JEV RNA and no cross-reactivity with other viruses.•Naked-eye one-tube RAVI-CRISPR assay for point-of-care testing of JEV was further developed.
Early and rapid detection of Japanese encephalitis virus (JEV) is necessary for timely preventive and control measures. However, JEV RNA detection remains challenging due to the low level of viremia. In this study, a RApid VIsual CRISPR (RAVI-CRISPR) assay based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) and CRISPR/Cas12a targeting was developed for easy detection of JEV in the field. We showed successful detection of 8.97 or more copies of the C gene sequence of JEV RNA within approximately 60 min. This assay also displayed no cross-reactivity with other porcine pathogens. We applied our one-tube RAVI-CRISPR assay to 18 brain tissue sample for JE diagnosis. The results from both fluorescence intensity measurements and directly naked-eye visualization were consistent with those from real-time PCR analysis. Taken together, our results showed that one-tube RAVI-CRISPR assay is robust, convenient, sensitive, specific, affordable, and potentially adaptable to on-site detection or surveillance of JEV in clinical and vector samples. |
---|---|
ISSN: | 0168-1702 1872-7492 |
DOI: | 10.1016/j.virusres.2022.198869 |